NCT04531527View on ClinicalTrials.gov

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 24, 2013

Primary Completion Date

June 28, 2013

Study Completion Date

June 28, 2013

Conditions

Dermatitis, Phototoxic

Interventions

DRUG

Butenafine HCl 1% (BAY1896425)

Approximately 60 μl of Butenafine HCl 1% applied twice to the treated irradiated site and to the treated non-irradiated site for a total application of 240 μl of Butenafine HCl 1%.

Trial Locations (1)

07004

Fairfield